fbpx Skip to main content

BioCommunique Article

The race for solutions continues, with our members at the forefront, and Biocom is stepping up to bring collaborations between California companies to life.

Uniting Life Sciences to Tackle COVID-19 From All Angles

  • 2020-04-06T22:24:00.000+0000
  • California
  • Author: Lauren Panetta

Since the emergence of COVID-19, Biocom has seen our members rapidly step up their efforts to help understand, diagnose, and treat the novel coronavirus with companies teaming up to tackle the pandemic from all angles. Several therapeutics are now in clinical trials and more than 20 vaccines are in development with many members within our California life science community leading the charge. Check out all that Biocom’s members are working on related to COVID-19 at our coronavirus resource center, which is updated daily to show the latest breakthroughs, collaborations, and developments.

Supporting those working on the frontlines in our hospitals and our members focused on life-saving solutions continues to be our goal during this time. To connect companies with capacity to those in need, we recently launched a Coronavirus Partnering portal and we’ve already experienced an overwhelming response from hundreds of companies eager to collaborate with others. If you are searching for a company to partner with or have a need, please contact us at covid19@biocom.org so we can help facilitate a potential partnership.

In San Diego Mayor Faulconer’s COVID-19 update from the City of San Diego, Biocom’s President & CEO, Joe Panetta, discussed how San Diego’s life science industry is coming together to eradicate COVID-19. “I want all San Diegans to take pride in this life science community that we’ve grown over 40 years here in San Diego.” Panetta went on to mention the work of San Diego companies, stating that, “In the last few months and in the future, there will be an aggressive effort to mitigate the impact of the coronavirus which will be led by researchers, technicians, engineers, scientists, and others here in our San Diego life science community.” The work of San Diego companies spans across all areas of tackling the virus, and includes the work of Hologic, Thermo Fisher Scientific, Quidel, Sorrento Therapeutics, Takeda, Gilead, Inovio, Arcturus, BD, and Illumina.

To bring together San Diego’s elected officials with local life science companies working on COVID-19 diagnostics, treatments, and vaccines, Biocom held a video conference on March 24th with Mayor Faulconer, Council President Pro Tem Barbara Bry, and eleven Biocom members. Our public policy team continues to work with all level of government to keep officials informed on the leadership and expertise our California life science industry brings.

Donations continue to pour in as our team fields calls from companies and individuals across the state who wish to donate medical and lab supplies such as gloves, N95 masks, goggles, and other PPE. For those with additional supplies, visit our donations page to see requests made by healthcare systems in the Bay Area, Los Angeles, and San Diego and how you can help.